Rallybio Corporation (RLYB)
NASDAQ: RLYB · IEX Real-Time Price · USD
1.325
-0.015 (-1.12%)
Jul 22, 2024, 11:51 AM EDT - Market open

Rallybio Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Year Ending
CurrentDec 31, 2023Dec 31, 2022Dec 31, 2021
Market Capitalization
5590210307
Market Cap Growth
-67.82%-57.08%-31.34%-
Enterprise Value
-38-1942131
PE Ratio
--1.21-3.16-6.52
PB Ratio
0.620.851.241.75
P/FCF Ratio
-1.23-1.50-3.67-6.68
P/OCF Ratio
-1.23-1.50-3.67-6.73
EV/EBITDA Ratio
0.310.26-0.63-2.80
EV/EBIT Ratio
0.310.26-0.63-2.79
EV/FCF Ratio
0.420.32-0.73-2.86
Debt / Equity Ratio
0.000.000.00-
Debt / EBITDA Ratio
0.00-0.01-0.01-
Debt / FCF Ratio
-0.01-0.01-0.01-
Quick Ratio
9.3411.8715.7326.76
Current Ratio
9.7712.3916.7127.61
Interest Coverage
----4700.30
Return on Equity (ROE)
-66.60%-56.90%-43.60%-80.40%
Return on Assets (ROA)
-61.50%-53.40%-41.10%-30.10%
Return on Capital (ROIC)
-89.77%-74.06%-39.96%-26.00%
Earnings Yield
-137.33%-82.55%-31.67%-15.34%
FCF Yield
-102.57%-66.73%-27.24%-14.96%
Buyback Yield / Dilution
-1.30%-27.11%-24.70%-46.76%
Total Shareholder Return
-1.30%-27.11%-24.70%-46.76%
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).